Medipharm Labs Corp T.LABS

Alternate Symbol(s): MEDIF

Healthcare Cannabis

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. It also sells metered dose inhalers and aerosol sublingual sprays. Through Harvest Medicine, it provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.

TSX:LABS - Post by User

Medipharm Labs Corp > No earnings call, only presentation.

<< Previous

Bullboard Posts

Next >>

Comment by QContinuum1on Nov 11, 2024 10:42am

98 Views

Post# 36306522

RE:RE:RE:No earnings call, only presentation.

Lemoyne wrote: QC, what will you make of it if Q3 has positive EBITDA?

They were within a breath of it last Q, so what I make of it is much ado about nothing. If topline has flatlined, then breakeven doesn't move the SP needle apart from confirming that the cash runway is a bit longer which has been long priced in IMO.

I'd be happy with an equity stake from a big player (say pharma) or a takeout >$1. Anything other than that, I won't be happy. The business is long past lip service. This year was all about execution and growth and, so far, nothing has really happened there.

<< Previous

Bullboard Posts

Next >>

AI companies to invest in